Although foreign studies have been conducted to evaluate the efficacy and safety of this product at a daily dose of 40 mg in children and adolescents aged 8-18 years, no data have been established in the Chinese population under 18 years of age. Therefore, it is not recommended for use in patients under 18 years of age at this time. Pravastatin is primarily indicated for patients with primary hypercholesterolemia that remains uncontrolled by dietary restriction, or in combination with hypertriglyceridemia. The adverse effects of the drug are mild and transient, mostly asymptomatic elevation of serum aminotransferases and mild non-specific gastrointestinal discomfort; it is contraindicated in those who are allergic to the drug, have active hepatitis or persistently elevated liver enzymes, and in pregnant and lactating women. The specific use of the drug is recommended under the guidance of a professional physician, do not take medication without authorization, to avoid adverse reactions, to achieve the therapeutic effect.